Medication Expert Witnesses in Delaware

This expert has been practicing toxicology for over 40 years. She holds a Master of Science in Clinical Chemistry as well as a Ph.D. in Toxicology, and an honorary doctoral degree in Medicine and Surgery from the Faculty of Medicine, University of Helsinki. She serves on the World Anti-Doping Agency's Prohibited List Committee, the National Commission on Forensic Sciences, the Organization of Scientific Area Committee on Toxicology, Transportation Research Board Committee on Alcohol and Other Drugs, and the National Safety Council's Alcohol, Drugs and Impairment Division Executive Board. She was a President of the International Association of Forensic Toxicologists, she is also a former President of the Society of Forensic Toxicologist and past Chair of the Toxicology Section of the American Academy of Forensic Sciences. She has published over 445 peer-reviewed articles and has presented more than 500 abstracts at national and international meetings, and she sits on the Editorial Board of multiple toxicological and chemical journals. She recently retired as Chief of Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health. She serves as an Adjunct Professor at a major medical university. She consults with the US Department of Transportation, NMS Labs, and other diagnostic companies around the world. The journal Clinical Chemistry identified her as an inspiring mind.

This expert is a board certified internal medicine doctor who has been working as an attending physician in a nursing home for over 30 years. He has extensive experience in dealing with patients who are at higher risk for falls.

This board-certified psychiatrist specializes in combined psychotherapy and medication management. He received his medical degree from King George's Medical College in India and completed a residency in Psychiatry at Howard University in DC. He received specialized training in treating children and adolescents from the University of Maryland, as well as postgraduate training in Forensic Psychiatry from the University of Pennsylvania. He is a member of the American Academy of Child and Adolescent Psychiatry and the American Academy of Psychiatry and the Law. He has been practicing psychiatry for over 16 years, and has evaluated patients in various settings, including inpatient, outpatient and consultation-liaison.

This expert is board certified psychiatrist and addiction specialist, and also is certified by the American Board of Disability Analysts. He is an expert in handling capital, personal injury, loss mitigation, malpractice and negligence cases that involve the use of abused substances (especially, opiates, alcohol, hallucinogens, and stimulants), prescribed pharmacological agents, and in the general field of psychiatric and brain disease. This expert also is a leading neuroscientist and neuropsychopharmacologist. He can provide expert testimony on the effects of different brain states and function, in both health and disease, and their potential association with with legal culpability and liability. He currently serves as the Chairman of the Department of Psychiatry at a leading university in the USA, and has over 12 years experience as Chairman in Psychiatry Departments in the USA. His research focus is in the neuropsychopharmacology of addiction, addiction and pain, pain treatment, impact of genetics on human behavior, the basic, molecular, and the brain imaging sciences related to the functioning of the brain in health, disease and addiction. In recognition of his academic, scholarly and professional achievement, he is a Fellow of the Collegium Internationale Neuro-psychopharmacologicum and a Distinguished Fellow of the American Psychiatric Association. He is the recipient of numerous professional and scientific awards, including the Jack Mendelson Award at the NIH, which is awarded to individuals who have made distinguished contributions to our understanding of the science of addiction. He has an h-index of 46, and 11829 citations of his published work.

This expert is Board of Governors Professor in the Institute for Health, Health Care Policy and Aging Research and the School of Social Work for a leading NJ University. At the Institute, he directs the Center for Health Services Research on Pharmacotherapy, Chronic Disease Management, and Outcomes, whose programs include the AHRQ-funded Center for Education and Research on Mental Health Therapeutics. He also is Chair of the Institute's Division on Aging and Associate Institute Director for Health Services Research. His work, which has resulted in more than 250 publications, includes many widely cited books and research articles on old-age policy and services for the elderly; on the use and outcomes of psychotropic medications and other mental health treatments; on HIV/AIDS care; and on numerous other health care and social policy topics. His work on gerontological policy and inequality has been particularly influential nationally, as the cumulative advantage model of aging which he originally proposed in the 1980s and has developed in a line of subsequent work has contributed to understanding of late-life inequalities and the way in which initial advantages such as educational attainment; social structures; health and economic events over the lifecourse; and public policies interact to shape late-life outcomes. He has also been an important contributor to research on long-term care and mental health among the elderly. His work on mental health services has contributed importantly to understanding problems of healthcare access, quality and disparities in large usual care populations, particularly those served by Medicare and Medicaid. Much of his recent work has focused on prescription drug use in society where he has pioneered important studies on treatment use, safety, and effectiveness, including current work on comparative effectiveness of treatments funded by the FDA and the Agency for Healthcare Research and Quality. In 2009, his contributions to scholarship on health services and outcomes were recognized by his appointment as Board of Governors Professor of Health Services Research at a leading NJ University with the university's Board of Governors citing his "major theoretical, methodological, and research contributions in the fields of aging, HIV care, and behavioral health; his highly influential and social policy scholarship; the impressive rigor of his cross-disciplinary research contributions that have shaped thinking, both in the U.S. and abroad, on issues confronting some of the most vulnerable groups in our society" and for his "numerous and enormously influential books, journal articles, reports, and other publications . and his outstanding contributions to improving decision-making in public policy as evidenced by his frequent invitations to testify before and advise Congress and other policymakers."

This extremely qualified neurologist with over 20 years of experience, hundreds of publications and abstracts, author of multiple books is a leading pioneer in his field. He completed his medical education in Tunisia and then completed his residency in neurology at Temple university, where he was appointed chief resident during his third and fourth year in training. He is a member of multiple societies and a reviewer of numerous medical journals. His clinical, academic and research experience makes this candidate extremely well rounded to handle any neurology case. He currently works as an attending physician and researcher at a highly ranked university affiliated medical center.

This biomedical engineer specializes in materials science and biomechanics. He earned his B.S. and Ph.D. from New Jersey Institute of Technology, where he also served as a Postdoctoral Research Scientist overseeing the development and execution of experiments measuring neuronal activity after traumatic brain injuries. The expert is now an Adjunct Professor in Biomedical Engineering departments at two New Jersey higher education institutions.

This accomplished senior finance executive has more than 30 years of experience within the global pharmaceuticals, healthcare, pharmacy benefits management and manufacturing industries. Most recently, he held the title of Vice President of Finance, Gross Margin Planning and Strategic Pricing with Express Scripts from April 2013 to March 2016. In this role, he managed the finances, strategic planning, business development, competitive intelligence and pricing for over $100 billion in annual revenue and associated gross margins across all business units. The expert previously held positions as a Market Group CFO & the Senior Vice President of the Employer & Key Accounts Group, the Vice President of Client Analysis & Account Management Planning, and the Vice President of Pricing & Underwriting. He has extensive experience overseeing negotiations and pricing for renewals and new sales. The expert earned his B.A. in Accounting & Business Administration and an M.B.A. in Finance from Rutgers University. He is currently an independent consultant.

This board certified psychiatrist offers psychotherapy, medication management, and clinical consultation to patients in Central Pennsylvania, including members of the Bucknell University and Susquehanna University communities as well as remotely via telepsychiatry to any resident of Pennsylvania and California. She completed her undergraduate education at Haverford College, where she focused on Cellular and Molecular Biology, and pursued her MD at the Temple University School of Medicine. She completed a postgraduate internship at the University of Pennsylvania and completed her residency in Psychiatry at the University of California at San Diego. In additional to her clinical practice, she has extensive experience in scientific writing, having served as an editor for several scholarly publications. She is experienced in psychological evaluations for court document submissions as well as expert testimony.